LuvAminos
ProductsResearchLoyaltyAffiliate ProgramContact us
Luvaminos

Research-grade peptides for laboratory and in-vitro research. Third-party tested, documented per batch.

(505) 460-8488

[email protected]

Shop

  • All Products

Resources

  • Research Library
  • Certificates of Analysis
  • Affiliate Program
  • Loyalty Program
  • Refer a Friend

Support

  • Contact Us
  • FAQ
  • Shipping Info
  • Returns & Refunds

Legal

  • Privacy Policy
  • Your Privacy Choices
  • Terms of Service
  • Affiliate Terms
  • Disclaimer
  • Research Use Only
Shop
  • All Products
Resources
  • Research Library
  • Certificates of Analysis
  • Affiliate Program
  • Loyalty Program
  • Refer a Friend
Support
  • Contact Us
  • FAQ
  • Shipping Info
  • Returns & Refunds
Legal
  • Privacy Policy
  • Your Privacy Choices
  • Terms of Service
  • Affiliate Terms
  • Disclaimer
  • Research Use Only

!FDA Disclaimer — Research Use Only

Statements regarding these products have not been evaluated by the U.S. Food and Drug Administration. These products are intended for laboratory and in-vitro research use only and are not for human or veterinary consumption of any kind. They are not drugs, foods, or supplements, are not FDA approved, and are not intended to diagnose, treat, cure, or prevent any disease. All products are sold exclusively to qualified researchers and must be handled by trained professionals. Read the full disclaimer →

© 2026 Luvaminos LLC. All Rights Reserved.

1209 Mountain Road PL NE STE R, Albuquerque, NM 87110

  • VisaVISA
  • Mastercard
  • American ExpressAMEX
  • DiscoverDiscover
  • Ethereum
  • SSL Secured
  • 99%+ Purity
  • Shipment Protection
Research/AHK-Cu

Dermal

AHK-Cu

A synthetic copper-binding tripeptide examined in hair-follicle, dermal papilla cell, and extracellular-matrix research models.

What It’s Studied For

AHK-Cu is a synthetic copper(II)-complexed tripeptide composed of three amino acids — alanine, histidine, and lysine — coordinated to a copper ion. It belongs to the copper-tripeptide family and is structurally a single-residue variant of the more extensively studied GHK-Cu, differing by an alanine-for-glycine substitution at the N-terminus. In the research literature it appears primarily in dermatology and hair-biology model systems — cultured dermal papilla cells and ex vivo human hair-follicle organ culture — and in copper-peptide biochemistry contexts.

  • Ex vivo human hair-follicle organ-culture model systems examining follicle elongation rate as a quantitative readout
  • Cultured human dermal papilla cell (DPC) proliferative activity and viability as assay endpoints
  • Apoptosis-pathway endpoints in follicular cell models (Bcl-2/Bax ratio, caspase-3, and PARP assessed by flow cytometry and western blot)
  • Dermal fibroblast and extracellular-matrix research contexts (VEGF and TGF-β1 expression endpoints, as a member of the copper-tripeptide class)
  • Copper(II) coordination chemistry of histidine-containing tripeptides (metal-binding and structural research)

Molecular Profile

Type

Synthetic copper(II)–tripeptide coordination complex

Molecular formula

C15H26N6O4

Molecular weight

~416.9 g/mol (AHK-Cu complex); free AHK tripeptide 354.40 g/mol

CAS number

682809-81-0

Amino acids

3

Sequence

Ala-His-Lys + Cu(II)

Modification

Copper(II) chelation via histidine imidazole and backbone nitrogen donor atoms; commonly supplied as the monohydrochloride salt.

Mechanism & Target Class

AHK-Cu is a copper(II)-complexed tripeptide in which the histidine imidazole side chain provides the principal metal-anchoring site, with copper(II) coordinated through nitrogen donor atoms — imidazole nitrogen together with backbone amide and terminal amine nitrogens — forming a stable chelate analogous in coordination motif to the GHK-Cu square-planar complex. The compound differs from GHK-Cu (Copper Tripeptide-1, Gly-His-Lys+Cu²⁺) only by an alanine-for-glycine substitution at the N-terminus, adding a methyl group that modestly increases lipophilicity and alters the three-dimensional geometry of the copper complex while preserving the conserved His-Lys copper-binding motif. In dermal model systems, the copper-tripeptide class is examined at the cellular level using endpoints including fibroblast and dermal papilla cell proliferative activity as a measured variable, and VEGF and TGF-β1 expression levels as molecular endpoints.

Research Focus

Studied in hair-follicle and dermal papilla cell biology, dermal fibroblast and extracellular-matrix research contexts, and copper-tripeptide coordination chemistry.

Hair-follicle and dermal papilla cell models

The primary AHK-Cu-specific study — Pyo et al. (2007), published in Archives of Pharmacal Research from the Department of Dermatology at Seoul National University College of Medicine — examined L-alanyl-L-histidyl-L-lysine-Cu²⁺ in two model systems: ex vivo human hair-follicle organ culture and cultured human dermal papilla cells (DPCs), the specialized mesenchymal fibroblasts at the base of the follicle. The study used follicle elongation rate and DPC proliferative activity as quantitative endpoints in each respective model system. Apoptosis-pathway endpoints in DPCs were further assessed using Annexin V-FITC/propidium iodide labeling by flow cytometry, while the Bcl-2/Bax ratio and cleaved forms of caspase-3 and PARP were examined by western blot. This study constitutes the principal primary literature specific to AHK-Cu in hair-follicle and dermal papilla cell biology.

Dermal fibroblast and extracellular-matrix context

Beyond the follicle-specific model, the copper-tripeptide class to which AHK-Cu belongs is studied in dermal fibroblast and extracellular-matrix (ECM) research contexts. The Pyo et al. (2007) work frames copper-tripeptide complexes in the context of dermal fibroblast proliferation and the expression of VEGF and TGF-β1 as endpoints of interest. The substantial body of fibroblast and ECM literature — encompassing collagen-pathway, matrix-remodeling, and matrix metalloproteinase endpoint work — was generated predominantly with GHK-Cu (Gly-His-Lys+Cu²⁺, Copper Tripeptide-1) rather than with AHK-Cu specifically; copper's role as a cofactor for ECM-related enzymes provides mechanistic context for the class, but GHK-Cu findings are not attributed to AHK-Cu in this dossier.

Copper coordination chemistry

A strand of literature characterizes how short histidine-containing peptides coordinate copper(II) ions, using potentiometric, UV/Vis, circular dichroism, and EPR methods. These studies establish that the imidazole nitrogen of histidine is the principal anchoring donor for Cu²⁺, with deprotonated amide nitrogens and the terminal amine completing the coordination sphere — a structural framework underlying the mechanistic understanding of AHK-Cu's metal-binding mode. Primary coordination-chemistry work on the specific Ala-His-Lys sequence is sparse; most published structural studies address GHK (Gly-His-Lys), Ala-His-Ala, the albumin N-terminal DAHK (Asp-Ala-His-Lys) motif, or related His-containing analogues rather than the AHK sequence directly.

Broader copper-peptide context and literature scope

AHK-Cu appears in the broader copper-peptide and angiogenesis research landscape. Primary studies of copper and VEGF expression in keratinocyte and dermal models (Sen et al., 2002) and review syntheses of the copper-tripeptide field — including comprehensive reviews of tripeptides in wound-repair and dermal research model contexts (Adnan et al., 2025) and gene-expression data syntheses for GHK-Cu (Pickart and Margolina, 2018; Pickart et al., 2015) — provide the surrounding scientific landscape. A 2025 clinical report (Kuceki et al., JAAD International) evaluated a combination microneedling/delivery protocol that included a copper peptide alongside other agents in a hair-loss model research context; because the design combined multiple agents, no independent contribution of the copper-peptide component can be attributed, and the compound was not specifically identified as AHK-Cu. The AHK-Cu-specific primary literature remains limited — anchored principally by the single Pyo et al. (2007) study — and GHK-Cu findings are not attributed to AHK-Cu throughout this dossier.

Storage & Handling

Lyophilized

Store sealed, protected from light and humidity, at freezer temperature for long-term stability in research settings.

Reconstituted

Refrigerate and protect from light

copper-peptide chelate stability is pH-sensitive.

As a copper chelate, integrity depends on maintaining the metal-peptide coordination; avoid competing chelators and extreme pH.

References

Reviews

  1. 1

    Adnan SB, Maarof M, Fauzi MB, Md Fadilah NI (2025). International Journal of Medical Sciences — Review of tripeptides including copper-tripeptides in wound-repair and skin-biology research model contexts

    DOI: 10.7150/ijms.118118
  2. 2

    Pickart L, Margolina A (2018). International Journal of Molecular Sciences — GHK-Cu copper tripeptide gene-expression data synthesis review (broader copper-peptide context)

    DOI: 10.3390/ijms19071987PubMed 29986520
  3. 3

    Pickart L, Vasquez-Soltero JM, Margolina A (2015). BioMed Research International — GHK peptide cellular-pathway modulation review in skin-biology research contexts (broader copper-peptide context)

    DOI: 10.1155/2015/648108

Reviews

  1. 4

    Pickart L (2008). Journal of Biomaterials Science Polymer Edition — Review of GHK tripeptide biology and tissue remodeling; ECM and repair research context (broader copper-tripeptide class context)

    DOI: 10.1163/156856208784909435PubMed 18644225

Clinical

  1. 5

    Kuceki G, Coppinger AJ, Ragi SD, Johnson LS, Goren A, Kalil LL, Cirino P, Wambier CG (2025). JAAD International — Combination microneedling-delivery protocol evaluation including copper peptide, minoxidil, and dutasteride in androgenetic alopecia (broader copper-peptide context; copper peptide not isolated, not identified as AHK-Cu)

    DOI: 10.1016/j.jdin.2025.01.012PubMed 40225275
  2. 6

    Miller TR, Wagner JD, Baack BR, Eisbach KJ (2006). Archives of Facial Plastic Surgery — Randomized clinical evaluation of topical copper tripeptide complex on CO2 laser-resurfaced skin (broader copper-tripeptide class context)

    DOI: 10.1001/archfaci.8.4.252PubMed 16847171

Primary research

  1. 7

    Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH (2007). Archives of Pharmacal Research — AHK-Cu in ex vivo human hair-follicle organ culture and cultured dermal papilla cells; apoptosis-pathway endpoints assessed

    DOI: 10.1007/BF02978833PubMed 17703734
  2. 8

    Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, Roy S (2002). American Journal of Physiology – Heart and Circulatory Physiology — Copper-induced VEGF expression examined in keratinocyte models and dermal models (broader copper-peptide biology context)

    PubMed 11959648
  3. 9

    Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP (1988). FEBS Letters — GHK-Cu stimulation of collagen synthesis in fibroblast cultures; concentration-response characterization (broader copper-tripeptide class context)

    DOI: 10.1016/0014-5793(88)80509-xPubMed 3169264
  4. 10

    Wegrowski Y, Maquart FX, Borel JP (1992). Life Sciences — GHK-Cu dose-dependent stimulation of sulfated glycosaminoglycan synthesis in fibroblast cultures (broader copper-tripeptide class context)

    DOI: 10.1016/0024-3205(92)90504-iPubMed 1522753
  5. 11

    Trachy RE, Fors TD, Pickart L, Uno H (1991). Annals of the New York Academy of Sciences — Peptide copper complex hair-follicle-stimulating properties examined in C3H mouse model (broader copper-tripeptide class context)

    DOI: 10.1111/j.1749-6632.1991.tb24420.xPubMed 1809108
  6. 12

    Uno H, Kurata S (1993). Journal of Investigative Dermatology — Chemical agents and peptides including copper-binding peptides examined in hair-growth primate and rat models (broader copper-peptide context)

    DOI: 10.1111/1523-1747.ep12363275PubMed 8326148
  7. 13

    Siméon A, Monier F, Emonard H, Gillery P, Birembaut P, Hornebeck W, Maquart FX (1999). Journal of Investigative Dermatology — MMP expression and activation in rat wounds modulated by GHK-Cu; in vivo wound model (broader copper-tripeptide class context)

    DOI: 10.1046/j.1523-1747.1999.00606.xPubMed 10383745
  8. 14

    Siméon A, Emonard H, Hornebeck W, Maquart FX (2000). Life Sciences — GHK-Cu stimulation of MMP-2 expression in cultured rat fibroblasts; copper-dependent effect (broader copper-tripeptide class context)

    DOI: 10.1016/s0024-3205(00)00803-1PubMed 11045606
  9. 15

    Siméon A, Wegrowski Y, Bontemps Y, Maquart FX (2000). Journal of Investigative Dermatology — GAG and small proteoglycan expression in rat wounds modulated by GHK-Cu; fibroblast culture endpoints (broader copper-tripeptide class context)

    DOI: 10.1046/j.1523-1747.2000.00166.xPubMed 11121126
  10. 16

    Pollard JD, Quan S, Kang T, Koch RJ (2005). Archives of Facial Plastic Surgery — Copper tripeptide (GHK-Cu) effects on normal and irradiated fibroblast proliferation and growth-factor expression; in vitro serum-free model (broader copper-tripeptide class context)

    DOI: 10.1001/archfaci.7.1.27PubMed 15655171
  11. 17

    Kloepper JE, Sugawara K, Al-Nuaimi Y, Gáspár E, van Beek N, Paus R (2010). Experimental Dermatology — Objective anagen/catagen distinction criteria established for human hair-follicle organ culture model systems

    DOI: 10.1111/j.1600-0625.2009.00939.xPubMed 19725870
  12. 18

    Hostynek JJ, Dreher F, Maibach HI (2010). Inflammation Research — In vitro human skin retention and penetration characterization of GHK-Cu across skin layers (broader copper-tripeptide class context)

    DOI: 10.1007/s00011-010-0214-4PubMed 20703511
  13. 19

    Sakuma S, Ishimura M, Yuba Y, Itoh Y, Fujimoto Y (2018). International Journal of Physiology, Pathophysiology and Pharmacology — GHK tripeptide examined as endogenous antioxidant; hydroxyl and peroxyl radical diminution in cell-free assay (broader copper-tripeptide class context)

    PubMed 30042814
  14. 20

    Choi HR, Kang YA, Ryoo SJ, Shin JW, Na JI, Huh CH, Park KC (2012). Journal of Peptide Science — Copper-free GHK tripeptide stem-cell marker restoration in skin; epidermal basal cell integrin expression endpoints (broader copper-tripeptide class context)

    DOI: 10.1002/psc.2455PubMed 23019153

Primary Database

PubChem CID 168431292↗

Also known as: Copper Tripeptide-3, L-Alanyl-L-histidyl-L-lysine-Cu(II)

Research Use Only

These products are intended for research purposes only and are not for human consumption. Not FDA approved. Not intended to diagnose, treat, cure, or prevent any disease.